> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on User Fee Financial Transparency
- URL: https://www.fdaweb.com/meeting-on-user-fee-financial-transparency-2/
- Published: 2019-05-13T12:00:00.000Z
- Updated: 2026-09-15T01:26:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144089

*Federal Register* notice: FDA has announced a 6/7 public meeting entitled “Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments.” The meeting is intended to review performance commitments included in the user fee agreements. It will also include presentations from FDA on the five-year plans for implementing resource capacity planning and modernized time reporting. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-05-13/pdf/2019-09803.pdf?ref=fdaweb.com).